What is AIRS's market cap?

$103.82M, based on the Nov 5 close of $1.44.

Does AirSculpt Technologies pay a dividend?

No regular cash dividend has been paid in the last year.

How much of AIRS is sold short?

3.0M shares, 16.4% of float, as of Oct 15, 2026.

What sector is AIRS in?

Healthcare, in the Offices & Clinics — Doctors industry.

NASDAQ · AIRSHealthcareOffices & Clinics — Doctors

AirSculpt Technologies, Inc. Common Stock (AIRS)

$1.44−15.29%

Close Nov 5, 2026 · split-adjusted

Nov 5, 2026$1.44▼ 85.02% in range

Nov 5, 2025Low $1.17 · High $10.49Nov 5, 2026

What changed · written from our data

As of Nov 5, 2026

AirSculpt Technologies closed at $1.44 on Nov 5, down 15.29%, 86.3% below its 52-week closing high. Volume of 710.1K shares was 0.89× its 20-day average (close to normal).

Split-adjusted performance: -20.9% over one month, -58.4% over six months, -84.0% over one year.

In the quarter ended Jun 30, 2026, revenue was $42.90M, down 2.5% from a year earlier, with a net margin of -2.6%.

Short interest was 3.0M shares at the Oct 15 settlement, down 1.7% from the prior report (16.4% of float, 3.5 days to cover).

Market cap$103.8M72.1M shares

Revenue · quarter$42.9M−2.5% YoY

Diluted EPS$-0.02—

P/E · TTM—P/S 0.7×

Net margin-2.6%Gross 61.4%

Dividend yieldNone$0.41 last paid

52-week range1.17 – 10.49−86.3% from high

Volume710.1K0.89× 20-day avg

Volatility · 60d100.3%Annualised

Short % of float16.4%3.5 days to cover

Net cash-$24.7MCash $18.8M

Next earnings—Not scheduled

Split-adjusted performance

1W −13.8%1M −20.9%3M −71.3%6M −58.4%YTD −27.3%1Y −84.0%3Y −76.0%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Offices & Clinics — Doctors

Percentile among 7 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −6.2%, revenue growth −2.5%, net margin −4.5%, P/E 10.5×.

Short interest

Details →

Shares short3.0M−1.7% vs prior

Days to cover3.5Settled Oct 15

% of float16.4%

Short vol. 10d54.0%of daily volume

Closest peers by size in Offices & Clinics — Doctors

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
AIRSAirSculpt Technologies	$1.44	−15.29%	−58.4%	−2.5%	−2.6%	—	$103.8M
LFMDLifeMD	$2.29	−6.53%	−49.0%	−3.5%	−16.6%	—	$110.5M	Compare
WSTNWestin Acquisition	$10.23	−0.29%	—	—	—	—	$80.9M	Compare
SBCSBC Medical Group Holdings Incorporated	$5.02	−5.64%	+56.4%	+13.4%	21.7%	10.5	$516.3M	Compare
STLNStarling Oncology	$6.70	−3.46%	—	—	—	—	$682.8M	Compare
TDOCTeladoc Health	$9.41	−2.99%	+35.2%	−3.4%	−4.5%	—	$1.72B	Compare
HIMSHims & Hers Health	$24.06	−9.75%	−6.2%	+38.2%	−11.5%	—	$5.61B	Compare

News about AirSculpt Technologies

All news →

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AirSculpt Technologies, Inc. - AIRSGlobeNewswire Inc. · Oct 6, 2026▼ Negative

Quick answers

What does AirSculpt Technologies do?: AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.
What is AIRS's market cap?: $103.82M, based on the Nov 5 close of $1.44.
Does AirSculpt Technologies pay a dividend?: No regular cash dividend has been paid in the last year.
How much of AIRS is sold short?: 3.0M shares, 16.4% of float, as of Oct 15, 2026.
What sector is AIRS in?: Healthcare, in the Offices & Clinics — Doctors industry.

About AirSculpt Technologies

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

HQ: Miami Beach, FL363 employeesListed Oct 29, 2021airsculpt.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology